ICON Public (ICLR) Stock Forecast & Price Target
$16.64B
Market Cap
48.18
P/E
20.42
Forward P/E
46
Score
ICLR price $215.71 +1.55 +0.72%
Stocklytics score rationale: value 60, quality 44, growth 35.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1666487000 | 1758439000 | 2595777000 | 2805839000 | 2797288000 | 5480826000 | 7741386000 | 8120176000 | 8281676000 | 8251340000 |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also…
Consensus Hold from 19 analysts. Average price target $173.82, -19.4% versus the current price. Low $105.00. High $207.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $173.82 for ICON Public Limited (ICLR), 19.6% below the current price of $216.08. Of 19 analysts covering the stock, 10 rate it Buy or Strong Buy, 8 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $105.00 |
|---|---|
| Average | $173.82 |
| High | $207.00 |
The average is 19.6% below the current price of $216.08.
Of 19 analysts, 10 rate ICON Public Limited Buy or Strong Buy, 8 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $10.56, revenue $8.14 billion. 2027, EPS $11.82, revenue $8.43 billion.
The Stocklytics Score for ICLR is 46 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$173.82 average, with a published range of $105.00 to $207.00.
The consensus is Hold from 19 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $10.56. The average revenue estimate is $8.14 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: ICON Public Limited · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$16.64B
Market Cap
48.18
P/E
20.42
Forward P/E
46
Score